Form 4: Genprex CEO Ryan Confer Reports Stock Transaction
SEC Form 4 Filing
Ryan Confer, President, CEO, and CFO of Genprex, Inc., reports the withholding of shares to cover tax obligations related to vested Restricted Stock Units.
Summary
- On February 18, 2025, Ryan Confer, the President, CEO, and CFO of Genprex, Inc., had 395 shares of common stock withheld to satisfy tax obligations.
- This transaction was related to the vesting of Restricted Stock Units (RSUs) previously granted under the company's 2018 Equity Incentive Plan.
- Following the transaction, Confer directly owns 38,743 shares of Genprex common stock.
Sentiment
Score: 5
Explanation: The document is a standard SEC filing related to a routine stock transaction. It doesn't inherently convey positive or negative sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders.
Stakeholder Impact
- The transaction has a minimal impact on stakeholders as it is a routine tax-related withholding of shares.
Key Dates
| Date | Description |
|---|---|
| 02/18/2025 | Date of stock transaction (withholding of shares for tax obligations). |
| 02/19/2025 | Date of signature for the Form 4 filing. |
Keywords
Genprex, Ryan Confer, stock transaction, Form 4, SEC, RSUs, equity incentive plan, beneficial ownership
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.